Wilma Bergfeld is a Dermatology physician. OpenAlex indexes 696 publications with 14,900 citations (h-index 59); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Dermatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9500 Euclid Ave
Cleveland, OH 441950001
Telephone
800-223-2273Registry record last updated 13 Dec 2011.
Clinical trials
- Treatment of Androgenetic Alopecia in Females, 12 Beam
Sponsor: Lexington International, LLC
- Facial Yoga Toning Program - A Pilot Study
Sponsor: The Cleveland Clinic
- Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva
Sponsor: The Cleveland Clinic
Overall officialPhase 2WithdrawnNCT00308204
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Eli Lilly and CompanyProgram year20251 payment
- SUN PHARMACEUTICAL INDUSTRIES INC.Program year20251 payment
- Galderma Laboratories, L.P.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
56.1%Arteriolar Vasodilator29.6%Minoxidil100%Part D≥29 patientsAldosterone antagonist (MRA)26.5%Spironolactone100%Part D≥24 patientsAnti-infectives
10%Azole Antifungal5.2%Ketoconazole100%Part D<11 patientsTetracycline-class Drug4.8%Doxycycline Monohydrate100%Part D<11 patientsDermatology
6.5%Corticosteroid6.5%Triamcinolone Acetonide100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”